{"id":185,"date":"2005-06-06T10:28:00","date_gmt":"2005-06-06T10:28:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/?p=185"},"modified":"2022-06-20T10:29:25","modified_gmt":"2022-06-20T10:29:25","slug":"grindeks-izteicis-velmi-pirkt-47-35-polijas-farmacijas-kompanijas-jelfa-akciju","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/grindeks-izteicis-velmi-pirkt-47-35-polijas-farmacijas-kompanijas-jelfa-akciju\/","title":{"rendered":"Grindeks izteicis v\u0113lmi pirkt 47.35% Polijas farm\u0101cijas komp\u0101nijas Jelfa akciju"},"content":{"rendered":"\n<p>A\/s Grindeks 6. j\u016bnij\u0101 iesniegusi Polijas R\u016bpniec\u012bbas att\u012bst\u012bbas a\u0123ent\u016brai (Industrial Development Agency (IDA)) savu pieteikumu farmaceitisk\u0101s komp\u0101nijas Jelfa akciju ieg\u0101dei. Grindeks pretend\u0113 uz valsts strukt\u016br\u0101m piedero\u0161o akciju paketi, kas veido 47.35% no kop\u0113j\u0101 uz\u0146\u0113muma Jelfa akciju skaita, un \u0161obr\u012bd gaida atbildi no IDA.<\/p>\n\n\n\n<p>K\u0101 zi\u0146ots iepriek\u0161, \u0161\u012b gada apr\u012bl\u012b a\/s Grindeks k\u0101 potenci\u0101ls investors sa\u0146\u0113ma&nbsp;<em>IDA<\/em>&nbsp;uzaicin\u0101jumu piedal\u012bties uz\u0146\u0113muma Jelfa valsts strukt\u016br\u0101m piedero\u0161\u0101s uz\u0146\u0113muma akciju da\u013cas privatiz\u0113\u0161an\u0101. A\/s Grindeks izskat\u012bjusi pied\u0101v\u0101jumu un pie\u0146\u0113musi l\u0113mumu pretend\u0113t uz uz\u0146\u0113muma&nbsp;<em>Jelfa<\/em>&nbsp;akciju da\u013cas pirk\u0161anu. P\u0113c m\u016bsu r\u012bc\u012bb\u0101 eso\u0161\u0101s inform\u0101cijas, Grindeks ir viens no vair\u0101kiem pretendentiem min\u0113t\u0101 Polijas uz\u0146\u0113muma akciju ieg\u0101dei.<\/p>\n\n\n\n<p>L\u0113mums par Jelfas akciju da\u013cas ieg\u0101di pie\u0146emts atbilsto\u0161i a\/s Grindeks strat\u0113\u0123iskajiem pl\u0101niem saist\u012bb\u0101 ar m\u0113r\u0137tiec\u012bgu farm\u0101cijas koncerna un savas darb\u012bbas m\u0113rogu papla\u0161in\u0101\u0161anu Baltij\u0101 un Eiropas valst\u012bs.<\/p>\n\n\n\n<p>Ieg\u016bstot noz\u012bm\u012bgu da\u013cu Polijas uz\u0146\u0113ma akciju, Grindeks redz iesp\u0113jas kop\u012bg\u0101 produktu portfe\u013ca papla\u0161in\u0101\u0161anai, izmantojot Grindeks zin\u0101tniski tehnolo\u0123isko potenci\u0101lu, un veiksm\u012bgi apvienojot akt\u012bvo farmaceitisko vielu ra\u017eotnes kapacit\u0101ti ar&nbsp;<em>Jelfas&nbsp;<\/em>gatavo z\u0101\u013cu ra\u017eo\u0161anas jaud\u0101m, \u012bpa\u0161i attiec\u012bb\u0101 uz medikamentu injekciju un zie\u017eu form\u0101m. Uz\u0146\u0113muma Jelfa iesaist\u012b\u0161ana Grindeks farm\u0101cijas koncern\u0101 \u013cautu apg\u016bt jaunus noieta tirgus, k\u0101 ar\u012b papildin\u0101t produktu pied\u0101v\u0101jumu eso\u0161ajos tirgos.<\/p>\n\n\n\n<p>Sadarb\u012bbu ar&nbsp;<em>Jelfu&nbsp;<\/em>Latvijas z\u0101\u013cu ra\u017eot\u0101js Grindeks uzs\u0101ka jau pag\u0101ju\u0161aj\u0101 gad\u0101, nosl\u0113dzot l\u012bgumu par Grindeks ori\u0123in\u0101lprodukta&nbsp;<em>Mildron\u0101ts&nbsp;<\/em>injekciju formas kontraktra\u017eo\u0161anu.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A\/s Grindeks 6. j\u016bnij\u0101 iesniegusi Polijas R\u016bpniec\u012bbas att\u012bst\u012bbas a\u0123ent\u016brai (Industrial Development Agency (IDA)) savu pieteikumu farmaceitisk\u0101s komp\u0101nijas Jelfa akciju ieg\u0101dei. Grindeks pretend\u0113 uz valsts strukt\u016br\u0101m&#8230;<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-185","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=185"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/185\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}